Comparison of Vaccine Platforms for Machupo Virus

Rachel I. Erickson(University of Pennsylvania), Paul Bates(University of Pennsylvania)

Vaccines

March 31, 2026

10.3390/vaccines14040315

Cited by 0

Related Papers

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

|Proceedings of the National Academy of Sciences|2004|572

Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein

|PLoS Pathogens|2010|145

Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein

|Viruses|2025|7